Odyssey Therapeutics, Inc. ⋅ 10-Q ⋅ 6/17 SMITH & WESSON BRANDS, INC. ⋅ 10-K ⋅ 6/17 Charlton Aria Acquisition Corp ⋅ 10-Q ⋅ 6/17 Skkynet Cloud Systems, Inc. ⋅ 10-Q ⋅ 6/17 INNOVATIVE DESIGNS INC ⋅ 10-Q ⋅ 6/17 Kindcard, Inc. ⋅ 10-Q ⋅ 6/17 LA-Z-BOY INC ⋅ 10-K ⋅ 6/16 Terra Innovatum Global N.V. ⋅ 10-K ⋅ 6/16 QuasarEdge Acquisition Corp ⋅ 10-Q ⋅ 6/16 Aimei Health Technology Co., Ltd. ⋅ 10-Q ⋅ 6/16

Odyssey Therapeutics, Inc. ⋅ 10-Q ⋅ 6/17 SMITH & WESSON BRANDS, INC. ⋅ 10-K ⋅ 6/17 Charlton Aria Acquisition Corp ⋅ 10-Q ⋅ 6/17 Skkynet Cloud Systems, Inc. ⋅ 10-Q ⋅ 6/17 INNOVATIVE DESIGNS INC ⋅ 10-Q ⋅ 6/17 Kindcard, Inc. ⋅ 10-Q ⋅ 6/17 LA-Z-BOY INC ⋅ 10-K ⋅ 6/16 Terra Innovatum Global N.V. ⋅ 10-K ⋅ 6/16 QuasarEdge Acquisition Corp ⋅ 10-Q ⋅ 6/16 Aimei Health Technology Co., Ltd. ⋅ 10-Q ⋅ 6/16

Odyssey Therapeutics, Inc.

Biological Products, (No Diagnostic Substances) | SIC: 2836
Phone: (212) 841-1000

CIK: 0001882782
EIN: 863384382
State Location: MA
State of Inc.: DE

Nasdaq:ODTX

Form: SCHEDULE 13G

Filing Date: 18 May 2026
Report Date:
Accepted: 18 May 2026 06:20 p.m.
Accession Number: 0002044377-26-000002

Act: 34
File Number: 005-95704
Film Number: 26995603

Documents

Primary Document

Accepted: 18 May 2026 06:20 p.m.

0002044377-26-000002-index-headers.html

Last Modified: 18 May 2026 06:20 p.m.

0002044377-26-000002-index.html

Last Modified: 18 May 2026 06:20 p.m.

0002044377-26-000002.txt

Last Modified: 18 May 2026 06:20 p.m.

ex-99-05192026_120500.htm

Last Modified: 18 May 2026 06:20 p.m.

primary_doc.xml

Last Modified: 18 May 2026 06:20 p.m.